177 related articles for article (PubMed ID: 35602011)
1. Identifying the Novel Inhibitors Against the Mycolic Acid Biosynthesis Pathway Target "mtFabH" of
Kumar N; Srivastava R; Mongre RK; Mishra CB; Kumar A; Khatoon R; Banerjee A; Ashraf-Uz-Zaman M; Singh H; Lynn AM; Lee MS; Prakash A
Front Microbiol; 2022; 13():818714. PubMed ID: 35602011
[TBL] [Abstract][Full Text] [Related]
2. The Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthase III activity is inhibited by phosphorylation on a single threonine residue.
Veyron-Churlet R; Molle V; Taylor RC; Brown AK; Besra GS; Zanella-Cléon I; Fütterer K; Kremer L
J Biol Chem; 2009 Mar; 284(10):6414-24. PubMed ID: 19074144
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthase III.
Scarsdale JN; Kazanina G; He X; Reynolds KA; Wright HT
J Biol Chem; 2001 Jun; 276(23):20516-22. PubMed ID: 11278743
[TBL] [Abstract][Full Text] [Related]
4. Identification and substrate specificity of beta -ketoacyl (acyl carrier protein) synthase III (mtFabH) from Mycobacterium tuberculosis.
Choi KH; Kremer L; Besra GS; Rock CO
J Biol Chem; 2000 Sep; 275(36):28201-7. PubMed ID: 10840036
[TBL] [Abstract][Full Text] [Related]
5. Probing the mechanism of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthase III mtFabH: factors influencing catalysis and substrate specificity.
Brown AK; Sridharan S; Kremer L; Lindenberg S; Dover LG; Sacchettini JC; Besra GS
J Biol Chem; 2005 Sep; 280(37):32539-47. PubMed ID: 16040614
[TBL] [Abstract][Full Text] [Related]
6. Biphenyl-based analogues of thiolactomycin, active against Mycobacterium tuberculosis mtFabH fatty acid condensing enzyme.
Senior SJ; Illarionov PA; Gurcha SS; Campbell IB; Schaeffer ML; Minnikin DE; Besra GS
Bioorg Med Chem Lett; 2003 Nov; 13(21):3685-8. PubMed ID: 14552758
[TBL] [Abstract][Full Text] [Related]
7. 3D-QSAR, molecular docking studies, and binding mode prediction of thiolactomycin analogs as mtFabH inhibitors.
Lu X; Chen Y; You Q
J Enzyme Inhib Med Chem; 2010 Apr; 25(2):240-9. PubMed ID: 19968566
[TBL] [Abstract][Full Text] [Related]
8. Acetylene-based analogues of thiolactomycin, active against Mycobacterium tuberculosis mtFabH fatty acid condensing enzyme.
Senior SJ; Illarionov PA; Gurcha SS; Campbell IB; Schaeffer ML; Minnikin DE; Besra GS
Bioorg Med Chem Lett; 2004 Jan; 14(2):373-6. PubMed ID: 14698162
[TBL] [Abstract][Full Text] [Related]
9. Structure-based virtual screening, molecular dynamics simulation and MM-PBSA toward identifying the inhibitors for two-component regulatory system protein NarL of
Kumar N; Srivastava R; Prakash A; Lynn AM
J Biomol Struct Dyn; 2020 Jul; 38(11):3396-3410. PubMed ID: 31422761
[TBL] [Abstract][Full Text] [Related]
10. X-ray crystal structure of Mycobacterium tuberculosis beta-ketoacyl acyl carrier protein synthase II (mtKasB).
Sridharan S; Wang L; Brown AK; Dover LG; Kremer L; Besra GS; Sacchettini JC
J Mol Biol; 2007 Feb; 366(2):469-80. PubMed ID: 17174327
[TBL] [Abstract][Full Text] [Related]
11. Antimycobacterial action of thiolactomycin: an inhibitor of fatty acid and mycolic acid synthesis.
Slayden RA; Lee RE; Armour JW; Cooper AM; Orme IM; Brennan PJ; Besra GS
Antimicrob Agents Chemother; 1996 Dec; 40(12):2813-9. PubMed ID: 9124847
[TBL] [Abstract][Full Text] [Related]
12. Mycobacterium tuberculosis beta-ketoacyl acyl carrier protein synthase III (mtFabH) assay: principles and method.
Sachdeva S; Reynolds KA
Methods Mol Med; 2008; 142():205-13. PubMed ID: 18437316
[TBL] [Abstract][Full Text] [Related]
13. In Silico Drug Design of Thiolactomycin Derivatives Against Mtb-KasA Enzyme to Inhibit Multidrug Resistance of Mycobacterium tuberculosis.
Durairaj DR; Shanmughavel P
Interdiscip Sci; 2019 Jun; 11(2):215-225. PubMed ID: 28856604
[TBL] [Abstract][Full Text] [Related]
14. Identification of 2-aminothiazole-4-carboxylate derivatives active against Mycobacterium tuberculosis H37Rv and the beta-ketoacyl-ACP synthase mtFabH.
Al-Balas Q; Anthony NG; Al-Jaidi B; Alnimr A; Abbott G; Brown AK; Taylor RC; Besra GS; McHugh TD; Gillespie SH; Johnston BF; Mackay SP; Coxon GD
PLoS One; 2009; 4(5):e5617. PubMed ID: 19440303
[TBL] [Abstract][Full Text] [Related]
15. Virtual screening and identification of promising therapeutic compounds against drug-resistant
Andrianov AM; Furs KV; Gonchar AV; Skrahina AM; Wang Y; Lyu LD; Tuzikov AV
J Biomol Struct Dyn; 2023 Dec; ():1-13. PubMed ID: 38088766
[TBL] [Abstract][Full Text] [Related]
16. Virtual screening and free energy estimation for identifying Mycobacterium tuberculosis flavoenzyme DprE1 inhibitors.
Niranjan Kumar ; Srivastava R; Prakash A; Lynn AM
J Mol Graph Model; 2021 Jan; 102():107770. PubMed ID: 33065513
[TBL] [Abstract][Full Text] [Related]
17. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
18. The biosynthesis of mycolic acids in Mycobacterium tuberculosis relies on multiple specialized elongation complexes interconnected by specific protein-protein interactions.
Veyron-Churlet R; Bigot S; Guerrini O; Verdoux S; Malaga W; Daffé M; Zerbib D
J Mol Biol; 2005 Nov; 353(4):847-58. PubMed ID: 16213523
[TBL] [Abstract][Full Text] [Related]
19. Thiolactomycin and related analogues as novel anti-mycobacterial agents targeting KasA and KasB condensing enzymes in Mycobacterium tuberculosis.
Kremer L; Douglas JD; Baulard AR; Morehouse C; Guy MR; Alland D; Dover LG; Lakey JH; Jacobs WR; Brennan PJ; Minnikin DE; Besra GS
J Biol Chem; 2000 Jun; 275(22):16857-64. PubMed ID: 10747933
[TBL] [Abstract][Full Text] [Related]
20. Computational insights into potential marine natural products as selective inhibitors of Mycobacterium tuberculosis InhA: A structure-based virtual screening study.
Jayaraman M; Gosu V; Kumar R; Jeyaraman J
Comput Biol Chem; 2024 Feb; 108():107991. PubMed ID: 38086160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
